BDBM732707 (R)—N-(1-(3-chlorophenyl)-2,2,2-trifluoroethyl)-5-cyano-N-ethylpyridine-3-sulfonamide (Example 251) and (S)—N-(1-(3-chlorophenyl)-2,2,2-trifluoroethyl)-5-cyano-N-ethylpyridine-3-sulfonamide (Example 252)::US20250115569, Example 251

SMILES CCN(C(c1cccc(Cl)c1)C(F)(F)F)S(=O)(=O)c1cncc(C#N)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 732707   

TargetVoltage-dependent R-type calcium channel subunit alpha-1E(Human)
Lario Therapeutics

US Patent
LigandPNGBDBM732707((R)—N-(1-(3-chlorophenyl)-2,2,2-trifluoroethyl)-5-...)
Affinity DataIC50: 66.1nMAssay Description:TBDMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent